31 Mar 2020
Assets30.38
Total Income28.83
Profit After Tax0.09
NET Worth3.06
Reserves and Surplus0.76
Total Borrowing0.15
Open 29th Mar 2023 · Close 3rd Apr 2023 · Listing 13th Apr 2023
The shares listed at ₹115.00, a 3.60% move from the issue price. Sotac Pharmaceuticals is a SME IPO with an issue size of ₹33.30 crore, proposed for listing on NSE SME. The offer opens on 29th Mar 2023 and closes on 3rd Apr 2023. The issue structure includes a fresh issue of ₹31.64 crore. The current listing schedule points to 13th Apr 2023.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1200 | ₹133,200 |
| Object | Amount |
|---|---|
| To Meet Working Capital Requirements | ₹10.80 Cr |
| Investment in Subsidiary | ₹7.00 Cr |
| Upgradation / Construction of Existing /New Building in the Existing Premises | ₹5.90 Cr |
| General Corporate Purpose | ₹7.40 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| EBITDA Margin |
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹1.92 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable Advertising, Marketing Expenses and Printing Expenses | ₹0.15 Cr |
| Fees Payable to Regulators including Stock Exchanges and other Intermediaries | ₹0.05 Cr |
| Fees payable to Peer Review Auditor | ₹0.01 Cr |
| Fees Payable to Market Maker (for Two Years) | ₹0.06 Cr |
| Escrow Bank Fees | ₹0.01 Cr |